NEWS - Aug 12, 2015 Relmada Therapeutics Announces Launch of New Website and Corporate Communication Channels Read more
NEWS - Aug 10, 2015 Relmada Therapeutics Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market Read more
NEWS - Jul 27, 2015 Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone Read more
NEWS - Jul 16, 2015 Relmada Therapeutics Appoints Charles J. Casamento to Its Board of Directors Read more
NEWS - Jun 29, 2015 Enrollment in Relmada Therapeutics' Proof-of-Concept Clinical Study for Novel Oral Formulations of Buprenorphine Reaches Halfway Mark Read more
NEWS - Jun 10, 2015 Relmada Therapeutics Successfully Completes Phase 1 Single Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone Read more
NEWS - May 27, 2015 Relmada Therapeutics to Present at the 2015 LD Micro Invitational Conference Read more
NEWS - May 12, 2015 Relmada Therapeutics Announces Notice of Allowance for U.S. Patent Covering SECUREL(TM), its Abuse-Deterrent, Extended-Release, Technology Platform for Opioids Read more
